VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 12 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $112,000 | -40.1% | 162,714 | -6.9% | 0.00% | 0.0% |
Q3 2019 | $187,000 | +48.4% | 174,714 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $126,000 | -43.8% | 174,714 | -0.1% | 0.00% | -50.0% |
Q1 2019 | $224,000 | +9.8% | 174,914 | +28.5% | 0.00% | 0.0% |
Q4 2018 | $204,000 | +13.3% | 136,114 | +9.2% | 0.00% | 0.0% |
Q3 2018 | $180,000 | +85.6% | 124,614 | +19.3% | 0.00% | +100.0% |
Q2 2018 | $97,000 | 0.0% | 104,414 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $97,000 | -16.4% | 104,414 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $116,000 | +61.1% | 104,414 | +131.6% | 0.00% | 0.0% |
Q3 2017 | $72,000 | -14.3% | 45,076 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $84,000 | -4.5% | 45,076 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $88,000 | +144.4% | 45,076 | +371.7% | 0.00% | 0.0% |
Q4 2016 | $36,000 | -10.0% | 9,556 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $40,000 | +37.9% | 9,556 | +28.4% | 0.00% | – |
Q2 2016 | $29,000 | – | 7,441 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GARRISON BRADFORD & ASSOCIATES INC | 20,000 | $14,000 | 0.02% |
Hartford Financial Management Inc. | 16,000 | $11,000 | 0.00% |
RBF Capital, LLC | 25,000 | $19,000 | 0.00% |
Koshinski Asset Management, Inc. | 20,000 | $14,000 | 0.00% |
Financial Advocates Investment Management | 23,097 | $16,000 | 0.00% |
D.A. DAVIDSON & CO. | 110,000 | $76,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 162,714 | $112,000 | 0.00% |
HighTower Advisors, LLC | 132,328 | $91,000 | 0.00% |
Virtu Financial LLC | 15,854 | $11,000 | 0.00% |
BlackRock Inc. | 31,631 | $22,000 | 0.00% |